ClearOne, Inc. Reports Second Quarter 2022 Financial Results
ClearOne Inc. (NASDAQ: CLRO) reported Q2 2022 revenue of $7.4 million, a 5% decline from $7.7 million in Q2 2021, attributed mainly to a 31% drop in video product revenue. Despite a 6% uptick in core audio conferencing products, gross profit fell to $2.8 million, with a margin of 38.1%. Operating expenses decreased by 14% year-over-year to $4.5 million. The GAAP net loss improved to $0.3 million or $0.01 per share, driven by a $1.5 million gain from a loan forgiveness. Cash reserves decreased significantly to $1.2 million compared to $4.1 million at year-end 2021.
- Core audio conferencing solutions achieved a 6% revenue increase year-over-year.
- Non-GAAP operating expenses decreased by 14% year-over-year to $3.7 million.
- GAAP net loss improved significantly from $1.6 million in Q2 2021 to $0.3 million in Q2 2022.
- Overall revenue declined 5% year-over-year due to a 31% drop in video products.
- GAAP gross profit decreased to $2.8 million from $3.4 million year-over-year.
- Cash reserves fell sharply to $1.2 million from $4.1 million at the end of 2021.
-
Overall Q2 revenue declines
5% year-over-year - Core audio conferencing solutions post impressive revenue growth
- Gross Margin increases marginally over Q1.
-
Non-GAAP Operating expenses decrease
14% year-over-year
"Our core audio conferencing products which include mixers and BMA Ceiling Tile-based solutions posted impressive year over year revenue growth in Q2. Our revenue performance was constrained due to our inability to fully meet the demands of our channel as we continue to fight the raw material shortages caused by the unprecedented global supply chain crisis that hasn't spared our industry," said
"We are fully prepared for the current challenges faced by
Recent Highlights
-
On
May 25, 2022 , ClearOne Board of Directors announcedDerek Graham as the Interim CEO, replacingZee Hakimoglu . -
On
May 27, 2022 , theU.S. District Court of the District of Delaware dismissed Shure’s tort claims with prejudice. Shure dropped these claims on the eve of the trial that happened inNovember 2021 , in whichClearOne prevailed over Shure's infringement claims.ClearOne argued that the dismissal of Shure's tort claims should be with prejudice but Shure wanted the dismissal to be without prejudice – in other words, Shure wanted to preserve the ability to re-assert the claims later. The court ruled inClearOne's favor. Our motion seeking fees is still pending with the Court.
Financial Summary
The Company uses certain non-GAAP financial measures and reconciles those to GAAP measures in the attached tables.
-
Revenue in 2022-Q2 was
, compared to$7.4 million in 2021-Q2 and$7.7 million in 2022-Q1. The decrease in year-over-year revenue was primarily due to a$7.5 million 31% decline in video products and a3% decline in microphones, which were partially offset by a6% increase in audio conferencing. The increase in revenue from core audio conferencing products continued to be driven by solutions incorporating our BMA-CT and BMA 360 beamforming microphone array ceiling tiles and professional audio mixers. Despite this year-over-year revenue growth in core audio conferencing products, revenue from our audio conferencing products and microphones remain far below levels achieved prior to infringement of our strategic patents.
-
GAAP gross profit in 2022-Q2 was
compared to$2.8 million in 2021-Q2 and$3.4 million in 2022-Q1. GAAP gross profit margin was$2.8 million 38.1% in 2022-Q2, compared to44.3% in 2021-Q2 and37.3% in 2022-Q1. The gross profit margin was negatively impacted due to increase in material costs due to continuing supply chain constraints, which were partially offset by reduced freight and tariff costs and a decrease in inventory obsolescence costs in 2022-Q2
Operating expenses in 2022-Q2 were , compared to$4.5 million in 2021-Q2 and$4.9 million in 2022-Q1. Non-GAAP operating expenses in 2022-Q2 were$4.7 million , compared to$3.7 million in 2021-Q2 and$4.3 million in 2022-Q1. The year over year decrease in Non-GAAP operating expenses was mainly due to reduction in employee related expenses and consultant expenses caused by a decrease in headcount.$4.0 million
-
GAAP net loss in 2022-Q2 was
, or$0.3 million per share, compared to net loss of$0.01 , or$1.6 million per share, in 2021-Q2 and net loss of$0.08 , or$2.0 million per share, in 2022-Q1. The decrease in net loss was mainly due to the recognition of$0.08 in gain from the forgiveness of CARES Act Paycheck Protection Program Loan.$1.5 million
-
Non-GAAP net loss in 2022-Q2 was
, or$1.1 million per share, compared to net loss of$0.04 , or$1.0 million per share, in 2021-Q2 and net loss of$0.05 , or$1.3 million per share, in 2022-Q1.$0.05
($ in 000, except per share) |
|
Three months ended |
|
Six months ended |
|
||||||||||||||||
|
|
2022 |
|
|
|
2021 |
|
|
Change in %
|
|
|
2022 |
|
|
|
2021 |
|
|
Change in %
|
|
|
GAAP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Revenue |
$ |
7,375 |
|
|
$ |
7,735 |
|
|
(5 |
) |
$ |
14,920 |
|
|
$ |
14,773 |
|
$ |
1 |
|
|
Gross profit |
|
2,807 |
|
|
|
3,424 |
|
|
(18 |
) |
|
5,623 |
|
|
|
6,427 |
|
|
(13 |
) |
|
Operating expenses |
|
4,456 |
|
|
|
4,910 |
|
|
9 |
|
9,125 |
|
|
|
9,437 |
|
|
3 |
|
||
Operating loss |
|
(1,649 |
) |
|
|
(1,486 |
) |
|
(11 |
) |
|
(3,502 |
) |
|
|
(3,010 |
) |
|
(16 |
) |
|
Net loss |
|
(257 |
) |
|
|
(1,586 |
) |
|
84 |
|
(2,224 |
) |
|
|
(3,241 |
) |
|
31 |
|
||
Diluted loss per share |
|
(0.01 |
) |
|
|
(0.08 |
) |
|
88 |
|
|
(0.09 |
) |
|
|
(0.17 |
) |
|
47 |
|
|
Non-GAAP |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Non-GAAP gross profit |
$ |
2,809 |
|
|
$ |
3,426 |
|
|
(18 |
) |
$ |
5,627 |
|
|
$ |
6,432 |
|
$ |
(13 |
) |
|
Non-GAAP operating expenses |
|
3,746 |
|
|
4,336 |
|
|
14 |
|
|
7,712 |
|
|
|
8,324 |
|
|
(7 |
) |
||
Non-GAAP operating loss |
|
(937 |
) |
|
|
(910 |
) |
|
(3 |
) |
|
(2,085 |
) |
|
|
(1,892 |
) |
|
(10 |
) |
|
Non-GAAP net loss |
|
(1,073 |
) |
|
|
(1,010 |
) |
|
(6 |
) |
|
(2,335 |
) |
|
|
(2,123 |
) |
|
(10 |
) |
|
Non-GAAP Adjusted EBITDA |
|
(892 |
) |
|
|
(802 |
) |
|
(11 |
) |
|
(1,961 |
) |
|
|
(1,688 |
) |
|
(16 |
) |
|
Non-GAAP loss per share (diluted) |
|
(0.04 |
) |
|
|
(0.05 |
) |
|
20 |
|
|
(0.10 |
) |
|
|
(0.11 |
) |
|
14 |
|
Balance Sheet Highlights
As of
About
Non-GAAP Financial Measures
To supplement our consolidated financial statements presented on a GAAP basis,
Forward Looking Statements
This release contains “forward-looking” statements that are based on present circumstances and on ClearOne’s predictions with respect to events that have not occurred, that may not occur, or that may occur with different consequences and timing than those now assumed or anticipated. Such forward-looking statements and any statements of the plans and objectives of management for future operations and forecasts of future growth and value and the possible outcomes of litigation, are not guarantees of future performance or results and involve risks and uncertainties that could cause actual events or results to differ materially from the events or results described in the forward-looking statements. Such forward-looking statements are made only as of the date of this release and
In particular, the financial information contained herein is subject to and qualified by reference to the financial statements contained in the 10-Q, including the footnotes thereto, as well as the Company’s annual report on Form 10-K for the year ended
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS (Dollars in thousands, except par value) |
||||||||
|
|
|
|
|
|
|
||
ASSETS |
|
|
|
|
|
|
|
|
Current assets: |
|
|
|
|
|
|
|
|
Cash and cash equivalents |
|
$ |
1,203 |
|
|
$ |
1,071 |
|
Marketable securities |
|
|
— |
|
|
|
1,790 |
|
Receivables, net of allowance for doubtful accounts of |
|
|
4,112 |
|
|
|
4,991 |
|
Inventories, net |
|
|
9,858 |
|
|
|
10,033 |
|
Income tax receivable |
|
|
7,535 |
|
|
|
7,535 |
|
Prepaid expenses and other assets |
|
|
2,924 |
|
|
|
4,021 |
|
Total current assets |
|
|
25,632 |
|
|
|
29,441 |
|
Long-term marketable securities |
|
|
— |
|
|
|
1,220 |
|
Long-term inventories, net |
|
|
2,985 |
|
|
|
3,567 |
|
Property and equipment, net |
|
|
614 |
|
|
|
744 |
|
Operating lease - right of use assets, net |
|
|
1,237 |
|
|
|
1,537 |
|
Intangibles, net |
|
|
24,289 |
|
|
|
25,086 |
|
Other assets |
|
|
4,592 |
|
|
|
4,597 |
|
Total assets |
|
$ |
59,349 |
|
|
$ |
66,192 |
|
LIABILITIES AND SHAREHOLDERS' EQUITY |
|
|
|
|
|
|
|
|
Current liabilities: |
|
|
|
|
|
|
|
|
Accounts payable |
|
$ |
2,047 |
|
|
$ |
5,388 |
|
Accrued liabilities |
|
|
2,570 |
|
|
|
2,549 |
|
Deferred product revenue |
|
|
43 |
|
|
|
54 |
|
Short-term debt |
|
|
810 |
|
|
|
3,481 |
|
Total current liabilities |
|
|
5,470 |
|
|
|
11,472 |
|
Long-term debt, net |
|
|
1,184 |
|
|
|
1,535 |
|
Operating lease liability, net of current |
|
|
717 |
|
|
|
1,026 |
|
Other long-term liabilities |
|
|
655 |
|
|
|
655 |
|
Total liabilities |
|
|
8,026 |
|
|
|
14,688 |
|
|
|
|
|
|
|
|
|
|
Shareholders' equity: |
|
|
|
|
|
|
|
|
Common stock, par value |
|
|
24 |
|
|
|
22 |
|
Additional paid-in capital |
|
|
74,861 |
|
|
|
72,795 |
|
Accumulated other comprehensive loss |
|
|
(266 |
) |
|
|
(241 |
) |
Accumulated deficit |
|
|
(23,296 |
) |
|
|
(21,072 |
) |
Total shareholders' equity |
|
|
51,323 |
|
|
|
51,504 |
|
Total liabilities and shareholders' equity |
|
$ |
59,349 |
|
|
$ |
66,192 |
|
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Dollars in thousands, except per share values) |
||||||||||||||||
|
|
Three months ended |
|
|
Six months ended |
|
||||||||||
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
Revenue |
|
$ |
7,375 |
|
|
$ |
7,735 |
|
|
$ |
14,920 |
|
|
$ |
14,773 |
|
Cost of goods sold |
|
|
4,568 |
|
|
|
4,311 |
|
|
|
9,297 |
|
|
|
8,346 |
|
Gross profit |
|
|
2,807 |
|
|
|
3,424 |
|
|
|
5,623 |
|
|
|
6,427 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating expenses: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Sales and marketing |
|
|
1,562 |
|
|
|
1,755 |
|
|
|
3,122 |
|
|
|
3,328 |
|
Research and product development |
|
|
1,177 |
|
|
|
1,487 |
|
|
|
2,530 |
|
|
|
2,761 |
|
General and administrative |
|
|
1,717 |
|
|
|
1,668 |
|
|
|
3,473 |
|
|
|
3,348 |
|
Total operating expenses |
|
|
4,456 |
|
|
|
4,910 |
|
|
|
9,125 |
|
|
|
9,437 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating loss |
|
|
(1,649 |
) |
|
|
(1,486 |
) |
|
|
(3,502 |
) |
|
|
(3,010 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Interest expense |
|
|
(94 |
) |
|
|
(107 |
) |
|
|
(195 |
) |
|
|
(219 |
) |
Other income, net |
|
|
1,505 |
|
|
15 |
|
|
1,508 |
|
|
|
10 |
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss before income taxes |
|
|
(238 |
) |
|
|
(1,578 |
) |
|
|
(2,189 |
) |
|
|
(3,219 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Provision for income taxes |
|
|
19 |
|
|
|
8 |
|
|
|
35 |
|
|
|
22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
$ |
(257 |
) |
|
$ |
(1,586 |
) |
|
$ |
(2,224 |
) |
|
|
(3,241 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic weighted average shares outstanding |
|
|
23,948,631 |
|
|
|
18,775,817 |
|
|
|
23,923,110 |
|
|
|
18,775,795 |
|
Diluted weighted average shares outstanding |
|
|
23,948,631 |
|
|
|
18,775,817 |
|
|
|
23,923,110 |
|
|
|
18,775,795 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic loss per share |
|
$ |
(0.01 |
) |
|
$ |
(0.08 |
) |
|
$ |
(0.09 |
) |
|
$ |
(0.17 |
) |
Diluted loss per share |
|
$ |
(0.01 |
) |
|
$ |
(0.08 |
) |
|
$ |
(0.09 |
) |
|
$ |
(0.17 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Comprehensive loss: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss |
|
|
(257 |
) |
|
|
(1,586 |
) |
|
|
(2,224 |
) |
|
|
(3,241 |
) |
Unrealized gain (loss) on available-for-sale securities, net of tax |
|
|
26 |
|
|
(3 |
) |
|
|
(2 |
) |
|
|
(5 |
) |
|
Change in foreign currency translation adjustment |
|
|
(12 |
) |
|
|
(10 |
) |
|
|
(23 |
) |
|
|
(22 |
) |
Comprehensive loss |
|
|
(243 |
) |
|
|
(1,599 |
) |
|
|
(2,249 |
) |
|
|
(3,268 |
) |
UNAUDITED RECONCILIATION OF GAAP MEASURES TO NON-GAAP MEASURES (Dollars in thousands, except per share values) |
||||||||||||||||
|
|
Three months ended |
|
|
Six months ended |
|
||||||||||
|
|
2022 |
|
|
2021 |
|
|
2022 |
|
|
2021 |
|
||||
GAAP gross profit |
|
$ |
2,807 |
|
|
$ |
3,424 |
|
|
$ |
5,623 |
|
|
$ |
6,427 |
|
Stock-based compensation |
|
|
2 |
|
|
|
2 |
|
|
|
4 |
|
|
|
5 |
|
Non-GAAP gross profit |
|
$ |
2,809 |
|
|
$ |
3,426 |
|
|
$ |
5,627 |
|
|
$ |
6,432 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP operating loss |
|
$ |
(1,649 |
) |
|
$ |
(1,486 |
) |
|
$ |
(3,502 |
) |
|
|
(3,010 |
) |
Stock-based compensation |
|
|
30 |
|
|
|
33 |
|
|
|
65 |
|
|
|
64 |
|
Amortization of intangibles |
|
|
682 |
|
|
|
543 |
|
|
|
1,352 |
|
|
|
1,054 |
|
Non-GAAP operating loss |
|
$ |
(937 |
) |
|
$ |
(910 |
) |
|
$ |
(2,085 |
) |
|
$ |
(1,892 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net loss |
|
$ |
(257 |
) |
|
$ |
(1,586 |
) |
|
$ |
(2,224 |
) |
|
|
(3,241 |
) |
Stock-based compensation |
|
|
30 |
|
|
|
33 |
|
|
|
65 |
|
|
|
64 |
|
Amortization of intangibles |
|
|
682 |
|
|
|
543 |
|
|
|
1,352 |
|
|
|
1,054 |
|
CARES Act PPP loan forgiveness |
|
|
(1,528 |
) |
|
|
— |
|
|
|
(1,528 |
) |
|
|
— |
|
Non-GAAP net loss |
|
$ |
(1,073 |
) |
|
$ |
(1,010 |
) |
|
$ |
(2,335 |
) |
|
$ |
(2,123 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net loss |
|
$ |
(257 |
) |
|
$ |
(1,586 |
) |
|
$ |
(2,224 |
) |
|
$ |
(3,241 |
) |
Number of shares used in computing GAAP loss per share (diluted) |
|
|
23,948,631 |
|
|
|
18,775,817 |
|
|
|
23,923,110 |
|
|
|
18,775,795 |
|
GAAP loss per share (diluted) |
|
$ |
(0.01 |
) |
|
$ |
(0.08 |
) |
|
$ |
(0.09 |
) |
|
$ |
(0.17 |
) |
Non-GAAP net loss |
|
$ |
(1,073 |
) |
|
$ |
(1,010 |
) |
|
$ |
(2,335 |
) |
|
$ |
(2,123 |
) |
Number of shares used in computing Non-GAAP loss per share (diluted) |
|
|
23,948,631 |
|
|
|
18,775,817 |
|
|
|
23,923,110 |
|
|
|
18,775,795 |
|
Non-GAAP loss per share (diluted) |
|
$ |
(0.04 |
) |
|
$ |
(0.05 |
) |
|
$ |
(0.10 |
) |
|
|
(0.11 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
GAAP net loss |
|
$ |
(257 |
) |
|
$ |
(1,586 |
) |
|
$ |
(2,224 |
) |
|
$ |
(3,241 |
) |
Stock-based compensation |
|
|
30 |
|
|
|
33 |
|
|
|
65 |
|
|
|
64 |
|
Depreciation |
|
|
68 |
|
|
|
93 |
|
|
|
144 |
|
|
|
194 |
|
Amortization of intangibles |
|
|
682 |
|
|
|
543 |
|
|
|
1,352 |
|
|
|
1,054 |
|
Interest expense |
|
|
94 |
|
|
|
107 |
|
|
|
195 |
|
|
|
219 |
|
CARES Act PPP loan forgiveness |
|
|
(1,528 |
) |
|
|
— |
|
|
|
(1,528 |
) |
|
|
— |
|
Provision for income taxes |
|
|
19 |
|
|
|
8 |
|
|
|
35 |
|
|
|
22 |
|
Non-GAAP Adjusted EBITDA |
|
$ |
(892 |
) |
|
$ |
(802 |
) |
|
$ |
(1,961 |
) |
|
$ |
(1,688 |
) |
View source version on businesswire.com: https://www.businesswire.com/news/home/20220809005473/en/
801-975-7200
investor_relations@clearone.com
http://investors.clearone.com
Source:
FAQ
What were ClearOne's Q2 2022 earnings results?
How did ClearOne's revenue perform in Q2 2022 compared to Q2 2021?
What factors contributed to ClearOne's revenue decline in Q2 2022?
What is ClearOne's outlook following the Q2 2022 results?